![]() |
Liver Diseases |
Free Subscription
2 BMC Cancer |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Liver Diseases is free of charge.
The impact of an RNA-binding protein group on regulating the
RSPO-LGR4/5-ZNRF3/RNF43 module and the immune microenvironment in hepatocellular
carcinoma.
BMC Cancer. 2025;25:751.
PubMed
Abstract available
Efficacy and safety of image-guided hypofractionated radiotherapy for
hepatocellular carcinoma with portal vein tumor thrombosis: a retrospective,
multicenter study.
BMC Cancer. 2025;25:736.
PubMed
Abstract available
Identification and validation of a lenvatinib resistance-related prognostic
signature in HCC, in which PFKFB4 contributes to tumor progression and lenvatinib
resistance.
BMC Gastroenterol. 2025;25:287.
PubMed
Abstract available
The non-high-density lipoprotein cholesterol to high-density lipoprotein
cholesterol ratio as a predictor of all cause and cardiovascular mortality in
United States adults with NAFLD: a prospective cohort study.
BMC Gastroenterol. 2025;25:288.
PubMed
Abstract available
Mapping of rehabilitation interventions and assessment methods for patients with
liver cirrhosis: a scoping review.
BMC Gastroenterol. 2025;25:291.
PubMed
Abstract available
Effectiveness and safety evaluation of terlipressin in the treatment of
intestinal paralysis in end-stage liver disease.
BMC Gastroenterol. 2025;25:286.
PubMed
Abstract available
Translation and validation of the Swedish version of the EORTC LMC-21, the
disease-specific questionnaire for assessing health-related quality of life in
patients with colorectal liver metastases.
BMC Gastroenterol. 2025;25:281.
PubMed
Abstract available
Remimazolam alleviates hepatic ischemia-reperfusion injury by activating FOXO1/3
signaling : Remimazolam alleviates hepatic ischemia reperfusion injury.
BMC Gastroenterol. 2025;25:283.
PubMed
Abstract available
Comparison of the predictive value of TyG index and METS-IR for OSA combined with
NAFLD: a retrospective observational study based on a physical examination
population.
BMC Gastroenterol. 2025;25:279.
PubMed
Abstract available
Laparoscopic in situ anatomical resection of posterosuperior liver segments:
preservation of segment 6 regardless of the presence of the inferior right
hepatic vein.
Br J Surg. 2025;112:znaf066.
PubMed
Predictive Factors of Post-ERCP Hepatic Decompensation in Patients with
Cirrhosis: A Retrospective Case-Control Study.
Dig Dis Sci. 2025 Apr 24. doi: 10.1007/s10620-025-09071.
PubMed
Abstract available
Integrated Analysis of PSMB8 Expression and Its Potential Roles in Hepatocellular
Carcinoma.
Dig Dis Sci. 2025 Apr 22. doi: 10.1007/s10620-025-09040.
PubMed
Abstract available
CT feature of irregular extensive ulceration as a predictor of liver metastasis
in gastric gastrointestinal stromal tumours.
Eur Radiol. 2025;35:2759-2768.
PubMed
Abstract available
Longitudinal evaluation of pediatric and young adult metabolic
dysfunction-associated steatotic liver disease defined by MR elastography.
Eur Radiol. 2025;35:2474-2486.
PubMed
Abstract available
Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United
States: Update 2024.
Gastroenterology. 2025 Feb 4:S0016-5085(25)00034.
PubMed
Abstract available
AI-based phenotyping of hepatic fiber morphology to inform molecular alterations
in metabolic dysfunction-associated steatotic liver disease.
Hepatology. 2025 Apr 22. doi: 10.1097/HEP.0000000000001360.
PubMed
Abstract available
Privacy and fidelity: The promise of synthetic data in hepatology research.
Hepatology. 2025 Apr 21. doi: 10.1097/HEP.0000000000001361.
PubMed
Letter to the Editor: Association of hepatitis B surface antigen and risk of
hepatocellular carcinoma in chronic hepatitis B patients with immune-tolerant
phase.
Hepatology. 2025 Apr 21. doi: 10.1097/HEP.0000000000001365.
PubMed
Increased risk of hepatocellular carcinoma in HBeAg-negative indeterminate phase
compared to HBeAg-negative chronic infection.
Hepatology. 2025 Apr 21. doi: 10.1097/HEP.0000000000001354.
PubMed
Abstract available
Reply: Association of hepatitis B surface antigen and risk of hepatocellular
carcinoma in chronic hepatitis B patients with immune-tolerant phase.
Hepatology. 2025 Apr 21. doi: 10.1097/HEP.0000000000001366.
PubMed
Bone mineral density trends in cirrhotic patients.
Indian J Gastroenterol. 2025 Apr 24. doi: 10.1007/s12664-025-01780.
PubMed
The external validation of Dallas Steatosis Index among Asian population: a
useful tool for metabolic dysfunction-associated steatotic liver disease
identification and prevention.
J Gastroenterol. 2025;60:621-631.
PubMed
Abstract available
Correction: Nrf2/ASPM axis regulated vasculogenic mimicry formation in
hepatocellular carcinoma under hypoxia.
J Gastroenterol. 2025 Apr 23. doi: 10.1007/s00535-025-02246.
PubMed
Risk of Hepatocellular Carcinoma Decreases After Antiviral Therapy-Induced HBsAg
Seroclearance.
J Gastroenterol Hepatol. 2025 Apr 24. doi: 10.1111/jgh.16973.
PubMed
Abstract available
Significant Hepatic Fat Loss after Metabolic Dysfunction-associated Steatotic
Liver Disease: Beware of Misclassification as Absence of Disease.
J Hepatol. 2025 Apr 22:S0168-8278(25)00250-8. doi: 10.1016/j.jhep.2025.
PubMed
Liver gene expression and its rewiring in hepatic steatosis are controlled by
PI3Kalpha-dependent hepatocyte signaling.
PLoS Biol. 2025;23:e3003112.
PubMed
Abstract available
Imaging-based assessment of muscles and malnutrition predict prognosis in
patients with primary hepatocellular carcinoma.
PLoS One. 2025;20:e0307458.
PubMed
Abstract available
Is the Transplantation of Elderly and DCD Donors in Low MELD Recipients
Justified: An Intent-to-treat Analysis.
Transplantation. 2025;109:823-831.
PubMed
Abstract available
Thank you for your interest in scientific medicine.